Kristin Fortier
Primary Care · Thibodaux, LANPI 1306963723
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $498 and has fallen 73.7% since, to $131 in 2025.
Across 53 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$167
- Fresenius USA Marketing, Inc.$131
- Novo Nordisk$98
- Alkermes, Inc.$82
- Merck$69
- Otsuka America Pharmaceutical, Inc.$69
- plus $321 from 15 others
What the payments were for
- Food & beverage$936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$936 in reported general payments places this provider in the 55th percentile of 106 primary care providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $10,472 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,288 |
| Nifedipine ErNifedipine | 33 | $315 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $286 |
| Levothyroxine Sodium | 20 | $252 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 44 | $247 |
| Gabapentin | 19 | $171 |
| Pantoprazole Sodium | 42 | $168 |
| Omeprazole | 20 | $166 |
| Metoprolol Succinate | 32 | $165 |
| Losartan Potassium | 26 | $144 |
| Duloxetine Hcl | 13 | $131 |
| Metformin Hcl | 40 | $125 |
| Atorvastatin Calcium | 33 | $114 |
| Amlodipine Besylate | 32 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $14 | $10,47211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 106 primary care providers in Louisiana.
Other primary care in Thibodaux
- Tabitha LukeThibodaux$1K
- Wendy TaylorShreveport$15K
- Jodi BurasCovington$14K
- Mia Schexnayder-DavisNew Orleans$10K
- Lourdes TorresMonroe$8K
- Danielle WebsterPrairieville$8K
- Alle NorrisCovington$6K
- Ariel GrahamRayville$6K
- Eleisa FloydHouma$6K
- Emily FusilierBaton Rouge$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.